ピラマル・ファーマ・ソリューションズと味の素バイオファーマサービスは、基本的に一つのことを目的とした提携を発表しました。抗体薬物複合体医薬品の早期開発から実際の商業化までの期間を短縮することです。
Otsuka Medical Devices got approval in Japan for the Paradise Ultrasound Renal…
Mitsubishi Corporation announced it has finished investing in Fullerton Health Pte. Ltd.…
Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid…
Terumo Corporation announced that it has a definitive agreement with OrganOx Limited…
Deerhold has launched the PRIZM platform. It helps healthcare stakeholders make data-driven…
JDSC Co., Ltd. has launched a smart factory project to advance pharmaceutical…
Elix, Inc., a Japan-based AI drug discovery company, is pleased to announce…
Nexus Dental Systems has launched Nexus Integrated Health. This new international venture…
Otsuka Medical Devices got approval in Japan for the Paradise Ultrasound Renal…
Mitsubishi Corporation announced it has finished investing in Fullerton Health Pte. Ltd.…
Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid…
Terumo Corporation announced that it has a definitive agreement with OrganOx Limited…
Deerhold has launched the PRIZM platform. It helps healthcare stakeholders make data-driven…
JDSC Co., Ltd. has launched a smart factory project to advance pharmaceutical…
Elix, Inc., a Japan-based AI drug discovery company, is pleased to announce…
Nexus Dental Systems has launched Nexus Integrated Health. This new international venture…
アカウントにサインインする